146 related articles for article (PubMed ID: 34752817)
1. Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.
Wang Y; Xie L; Zhu M; Guo Y; Tu Y; Zhou Y; Zeng J; Zhu L; Du S; Wang Z; Zhang Y; Liu X; Song E
Exp Eye Res; 2021 Dec; 213():108823. PubMed ID: 34752817
[TBL] [Abstract][Full Text] [Related]
2. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration.
Daftarian N; Zandi S; Piryaie G; Nikougoftar Zarif M; Ranaei Pirmardan E; Yamaguchi M; Behzadian Nejad Q; Hasanpour H; Samiei S; Pfister IB; Soheili ZS; Nakao S; Barakat A; Garweg JG; Ahmadieh H; Hafezi-Moghadam A
FASEB J; 2020 Jun; 34(6):8001-8011. PubMed ID: 32333612
[TBL] [Abstract][Full Text] [Related]
4. CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization.
Zhou Y; Zeng J; Tu Y; Li L; Du S; Zhu L; Cang X; Lu J; Zhu M; Liu X
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):37. PubMed ID: 33764399
[TBL] [Abstract][Full Text] [Related]
5. Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization.
Xu J; Tu Y; Wang Y; Xu X; Sun X; Xie L; Zhao Q; Guo Y; Gu Y; Du J; Du S; Zhu M; Song E
Biomed Pharmacother; 2020 Jan; 121():109606. PubMed ID: 31743875
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental choroidal neovascularization by curcumin in mice.
Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q
PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.
Izumi-Nagai K; Nagai N; Ohgami K; Satofuka S; Ozawa Y; Tsubota K; Ohno S; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1679-85. PubMed ID: 18385091
[TBL] [Abstract][Full Text] [Related]
8. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
9. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration.
Xu N; Bo Q; Shao R; Liang J; Zhai Y; Yang S; Wang F; Sun X
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4596-4605. PubMed ID: 31675076
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
Kang S; Roh YJ; Kim IB
Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
12. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization.
Liu X; Guo A; Tu Y; Li W; Li L; Liu W; Ju Y; Zhou Y; Sang A; Zhu M
Cell Death Dis; 2020 Nov; 11(11):1016. PubMed ID: 33247124
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice.
Roh YJ; Jee D; Rho CR; Cho WK; Kang S
Clin Exp Ophthalmol; 2016; 44(1):43-51. PubMed ID: 26221970
[TBL] [Abstract][Full Text] [Related]
15. Cinidium officinale and its Bioactive Compound, Butylidenephthalide, Inhibit Laser-Induced Choroidal Neovascularization in a Rat Model.
Lee YM; Lee YR; Kim JS; Kim YH; Kim J
Molecules; 2015 Nov; 20(11):20699-708. PubMed ID: 26610445
[TBL] [Abstract][Full Text] [Related]
16. Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
Will-Orrego A; Qiu Y; Fassbender ES; Shen S; Aranda J; Kotagiri N; Maker M; Liao SM; Jaffee BD; Poor SH
J Ocul Pharmacol Ther; 2018 Sep; 34(7):489-499. PubMed ID: 30188257
[TBL] [Abstract][Full Text] [Related]
17. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
18. Secretogranin III as a novel target for the therapy of choroidal neovascularization.
LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W
Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
20. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
